EGFR and cancer: Furthermore, as indicated by the KEGG enrichment analysis, the predominant pathways enriched were Central carbon metabolism in cancer, NF-kappa B signaling pathway, Osteoclast differentiation, Coronavirus disease-COVID-19, and EGFR tyrosine kinase inhibitor resistance.